Screener
Sana Biotechnology SANA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 50,000 shares authorized; zero shares issued and outstanding as of March 31, 2026 and December 31, 2025 | - | - |
| Common stock, $0.0001 par value; 750,000 shares authorized; 269,817 and 266,732 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 27 | 27 |
| Additional paid-in capital | 2,015,441 | 2,009,845 |
| Accumulated other comprehensive income (loss) | (2) | 28 |
| Accumulated deficit | (1,896,226) | (1,849,016) |
| Total stockholders' equity | 119,240 | 160,884 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's common stock?
- Sana Biotechnology (SANA) reported common stock of $27K in Q1 2026.
- How has Sana Biotechnology's common stock changed year-over-year?
- Sana Biotechnology's common stock increased by 17.4% year-over-year, from $23K to $27K.
- What is the long-term trend for Sana Biotechnology's common stock?
- Over 5 years (2020 to 2025), Sana Biotechnology's common stock has grown at a 68.3% compound annual growth rate (CAGR), from $2K to $27K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Sana Biotechnology's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude